IBTS Annual Report 2007.pdf - Irish Blood Transfusion Service

More documents

Recommendations

Info

4 “The most critical function of the IBTS is to maintain a consistent blood supply.” Annual Report 2007
5 Chief Executive’s Report I have pleasure in presenting the Annual Report for the IBTS for 2007. The most critical function of the IBTS is to maintain a consistent blood supply. This is achieved through the generosity of our donors who give the gift of life to those who are ill, require elective surgery and suffer major trauma. For this we are eternally grateful. Like any other organisation the IBTS is not immune to changes in society both from the social perspective and the economic environment. The forecast for the Irish economy is uncertain and could influence people’s willingness to donate. In these circumstances it is incumbent on the IBTS to examine how we conduct our affairs to ensure that we are dealing with the most relevant issues, that we are cognisant of what is happening within our business across the globe and that we do this in the most effective and efficient manner. Blood Supply The IBTS were able to meet hospital requirements during 2007. This was achieved despite an increase of 1.16% in the use of red cells and an 8.7% increase in the use of platelets. We have seen a 60% increase in the use of platelets over the past 5 years. In order to forecast future demand the IBTS will have to review the projected number of new cancer cases expected to arise in Ireland over the next decade and devise a strategy to deal with the resulting demand in platelets. It is clear that the current configuration of our platelets service will not be able to meet the expected treatment needs of patients. A Big Thank You to our selfless and committed donors and their families. Developments – Science and Technology There were a number of significant developments during the year which will enhance the service we provide to patients. The most important of these were: ■■ Haemochromatosis Programme ■■ Validation of single donor NAT on TIGRIS ■■ Introduction of Orbisac for platelet production using Platelet Additive Solution rather than plasma ■■ BOSS – just commenced at year end. This will provide much needed management information from Progesa in a timely manner It was planned that eProgesa would be live during 2007 but unfortunately due to a number of persistent difficulties the project was discontinued in March. This Irish Blood Transfusion Service
Page 1 and 2: Annual Report 2007
Page 3 and 4: Contents Our Values Excellence in s
Page 5: 3 Chairperson’s Message The prima
Page 9 and 10: 7 across all sections of the organi
Page 11 and 12: 9 National Medical Director’s Rep
Page 13 and 14: 11 throughout the year and will be
Page 15 and 16: 13 Optimising use of the donor’s
Page 17 and 18: 15 NATIONAL 2007 VS 2006 CUMULATIVE
Page 19 and 20: 17 Hospital Services Hospital Servi
Page 21 and 22: 19 Operating in an environment of c
Page 23 and 24: 21 In addition to the above referen
Page 25 and 26: 23 RNA, HCV RNA and HBV DNA in huma
Page 27 and 28: 25 In pursuit of excellence Quality
Page 29 and 30: 27 Supporting best practice in pati
Page 31 and 32: 29 The Eye bank also imports and is
Page 33 and 34: 31 Irish Unrelated Bone Marrow Regi
Page 35 and 36: 33 Implementing change and deliveri
Page 37 and 38: 35 Pension Costs and to disclose th
Page 39 and 40: 37 Corporate Governance The Board i
Page 41 and 42: 39 Statement of Board Members’ Re
Page 44: National Blood Centre James’s Str

IBTS Annual Report 2007.pdf - Irish Blood Transfusion Service

Create successful ePaper yourself

Delete template?

Save as template?